REQUEST A DEMO
Total
USD $0.00
Search more companies

Phoenix Pharma S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Phoenix Pharma S.A.S. Profile Updated: August 02, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Phoenix Pharma S.A.S. is a company in Ecuador, with a head office in Daule. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Phoenix Pharma S.A.S. was incorporated on February 21, 2022. 4 (2023) employees currently work for Phoenix Pharma S.A.S.. From the latest financial highlights, Phoenix Pharma S.A.S. reported a net sales revenue increase of 221.55% in 2023. During that time, Phoenix Pharma S.A.S.’s total assets grew by 15603.79%.

Headquarters
Via Daule, Solar 15
Daule; Guayas;

Contact Details: Purchase the Phoenix Pharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Phoenix Pharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Phoenix Pharma S.A.S. report to view the information.
Registered Capital:
Purchase the Phoenix Pharma S.A.S. report to view the information.
Incorporation Date:
February 21, 2022
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Phoenix Pharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
221.55%
Total operating revenue
221.55%
Net Profit (Loss) for the Period
N/A
Total assets
15603.79%
Total equity
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
4.65%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?